Alzheimer's drug aducanumab not approved for use in EU

Alzheimer's drug aducanumab not approved for use in EU

The European Medicines Agency has said no to approving a new drug for Alzheimer's disease in the EU. Aducanumab does not appear to be effective at treating adults with early-stage symptoms, the EMA said.

link

alzheimer's